Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Head and Neck Neoplasms × Gefitinib × Clear all

Status

Approved for marketing 1

Sponsor Class

Study Type

Interventional 19 Expanded_access 1

Sponsor

Cancer Type

Thoracic 1 Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 2 Head and Neck Neoplasms 1

Interventions

zenocutuzumab 1 ulixertinib 1 carbon-11 methionine 1 Methionine 1 Gefitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00684385 2019-03-14

An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and Neck

AstraZeneca

Approved for marketing

Head & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡